Restoration of FcRγ/Fyn signaling repairs central nervous system demyelination

Journal of Neuroscience Research

Volumn 85, Issue 5, 2007, Pages 954-966

  Seiwa, Chika ^a   Yamamoto, Masahiro ^a,b,c   Tanaka, Kayoko ^d   Fukutake, Masato ^a,b   Ueki, Toshiyuki ^a,b   Takeda, Shuichi ^b   Sakai, Risa ^a,c   Ishige, Atsushi ^c   Watanabe, Kenji ^c   Akita, Masumi ^d   Yagi, Takeshi ^e   Tanaka, Kotaro ^f   Asou, Hiroaki ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b TSUMURA AND CO   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Aging; Cuprizone; Herbal medicine; Myelin basic protein; Rho protein

Indexed keywords

CUPRIZONE; FC RECEPTOR; HERBACEOUS AGENT; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELIN BASIC PROTEIN; NINJIN YOEITO; PROTEIN KINASE FYN; RAC1 PROTEIN; RHO FACTOR; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; FYN PROTEIN, MOUSE; MONOAMINE OXIDASE INHIBITOR; NEUROPROTECTIVE AGENT; NEUROTOXIN; REN-SHEN-YANG-RONG-TANG;

AGING; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; KNOCKOUT GENE; MALE; MOUSE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN FUNCTION; REMYELINIZATION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CONVALESCENCE; DEMYELINATING DISEASE; DISEASE MODEL; DRUG EFFECT; FEMALE; GENETICS; METABOLISM; MOUSE MUTANT; NERVE REGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; REN SHEN YANG RONG TANG;

AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS; CENTRAL NERVOUS SYSTEM; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOAMINE OXIDASE INHIBITORS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN SHEATH; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PROTO-ONCOGENE PROTEINS C-FYN; RECEPTORS, IGG; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION;

EID: 34147204701     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21196     Document Type: Article

References (52)

1. Achiron A, Margalit R, Hershkoviz R, Markovits D, Reshef T, Melamed E, Cohen IR, Lider O. 1994. Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion. J Clin Invest 93:600-605.
2. Achiron A, Kishner I, Sarova-Pinhas I, Raz H, Faibel M, Stern Y, Lavie M, Gurevich M, Dolev M, Magalashvili D, Barak Y. 2004. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Arch Neurol 61:1515-1520.
3. Aoki K, Nakamura T, Matsuda M. 2004. Spatio-temporal regulation of Rac1 and Cdc42 activity during nerve growth factor-induced neurite outgrowth in PC12 cells. J Biol Chem 279:713-719 [E-pub 2003 Oct].
4. Arancibia-Carcamo CV, Osawa H, Arnett HA, Haskova Z, George AJ, Ono SJ, Ting JP, Streilein JW. 2004. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Eur J Immunol 34:471-480.
5. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. 2001. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116-1122.
6. Arnett HA, Wang Y, Matsushima GK, Suzuki K, Ting JP. 2003. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J Neurosci 23:9824-9832.
7. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD. 2004. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306:2111-2115.
8. Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A, Trapp BD, Bebo BF Jr, Rao MS, Sherman LS. 2005. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11:966-972 [E-pub 2005 Aug].
9. Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458-468.
10. Boggs JM, Yip PM, Rangaraj G, Jo E. 1997. Effect of posttranslational modifications to myelin basic protein on its ability to aggregate acidic lipid vesicles. Biochemistry 36:5065-5071.
11. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173.
12. Dyer CA. 2002. The structure and function of myelin: from inert membrane to perfusion pump. Neurochem Res 27:1279-1292.
13. Egashira N, Yuzurihara M, Hattori N, Sakakibara I, Ishige A. 2003. Ninjin-yoei-to (Ren-Shen-Yang-Rong-Tang) and Polygalae radix improves scopolamine-induced impairment of passive avoidance response in mice. Phytomedicine 10:467-473.
14. Eichberg J, Iyer S. 1996. Phosphorylation of myelin protein: recent advances. Neurochem Res 21:527-535.
15. Erickson AK, Payne DM, Martino PA, Rossomando AJ, Shabanowitz J, Weber MJ, Hunt DF, Sturgill TW. 1990. Identification by mass spectrometry of threonine 97 in bovine myelin basic protein as a specific phosphorylation site for mitogen-activated protein kinase. J Biol Chem 265:19728-19735.
16. Fragoso G, Martinez-Bermudez AK, Liu HN, Khorchid A, Chemtob S, Mushynski WE, Almazan G. 2004. Developmental differences in HO-induced oligodendrocyte cell death: role of glutathione, mitogen-activated protein kinases and caspase 3. J Neurochem 90:392-404.
17. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 98:4746-4751.
18. Hakoshima T, Shimizu T, Maesaki R. 2003. Structural basis of the Rho GTPase signaling. J Biochem 134:327-331.
19. Hoppe AD, Swanson JA. 2004. Cdc42, Rac1, and Rac2 display distinct patterns of activation during phagocytosis. Mol Biol Cell 15:3509-3519 [E-pub 2004 May].
20. Ishikawa Y, Katoh H, Nakamura K, Mori K, Negishi M. 2002. Developmental changes in expression of small GTPase RhoG mRNA in the rat brain. Brain Res Mol Brain Res 106:145-150.
21. Jurevics H, Largent C, Hostettler J, Sammond DW, Matsushima GK, Kleindienst A, Toews AD, Morell P. 2002. Alterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination. J Neurochem 82:126-136.
22. Kim JK, Mastronardi FG, Wood DD, Lubman DM, Zand R, Moscarello MA. 2003. Multiple sclerosis: an important role for post-translational modifications of myelin basic protein in pathogenesis. Mol Cell Proteomics 2:453-462 [E-pub 2003 Jun].
23. Knox CA, Kokmen E, Dyck PJ. 1989. Morphometric alteration of rat myelinated fibers with aging. J Neuropathol Exp Neurol 48:119-139.
24. Kobayashi J, Seiwa C, Sakai T, Gotoh M, Komatsu Y, Yamamoto M, Fukutake M, Matsuno K, Sakurai Y, Kawano Y, Asou H. 2003. Effect of a traditional Chinese herbal medicine, Ren-Shen-Yang-Rong-Tang ( Japanese name: Ninjin-Youei-To), on oligodendrocyte precursor cells from aged-rat brain. Int Immunopharmacol 3:1027-1039.
25. Liang X, Draghi NA, Resh MD. 2004. Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci 24:7140-7149.
26. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500-508.
27. Marcus R, Eric P, Gabriel KR. 1976. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 63:655-660.
28. Marner L, Nyengaard JR, Tang Y, Pakkenberg B. 2003. Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol 462:144-152.
29. Mason JL, Jones JJ, Taniike M, Morell P, Suzuki K, Matsushima GK. 2000. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 61:251-262.
30. Mason JL, Langaman C, Morell P, Suzuki K, Matsushima GK. 2001. Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal caliber. Neuropathol Appl Neurobiol 27:50-58.
31. Matsushima GK, Morell P. 2001. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107-116.
32. Matute C, Perez-Cerda F. 2005. Multiple sclerosis: novel perspectives on newly forming lesions. Trends Neurosci 28:173-175.
33. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB. 2005. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8:745-751 [E-pub 2005 May].
34. Morell P, Barrett CV, Mason JL, Toews AD, Hostettler JD, Knapp GW, Matsushima GK. 1998. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol Cell Neurosci 12:220-227.
35. Nakahara J, Aiso S. 2006. Fc receptor-positive cells in remyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 65:582-591.
36. Nakahara J, Tan-Takeuchi K, Seiwa C, Gotoh M, Kaifu T, Ujike A, Inui M, Yagi T, Ogawa M, Aiso S, Takai T, Asou H. 2003. Signaling via immunoglobulin Fc receptors induces oligodendrocyte precursor cell differentiation. Dev Cell 4:841-852.
37. Niederost B, Oertle T, Fritsche J, McKinney RA, Bandtlow CE. 2002. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci 22:10368-10376.
38. Ridsdale RA, Beniac DR, Tompkins TA, Moscarello MA, Harauz G. 1997. Three-dimensional structure of myelin basic protein. II. Molecular modeling and considerations of predicted structures in multiple sclerosis. J Biol Chem 272:4269-4275.
39. Rogers KK, Jou TS, Guo W, Lipschutz JH. 2003. The Rho family of small GTPases is involved in epithelial cystogenesis and tubulogenesis. Kidney Int 63:1632-1644.
40. Seiwa C, Sugiyama I, Yagi T, Iguchi T, Asou H. 2000. Fyn tyrosine kinase participates in the compact myelin sheath formation in the central nervous system. Neurosci Res 37:21-31.
41. Seiwa C, Nakahara J, Komiyama T, Katsu Y, Iguchi T, Asou H. 2004. Bisphenol A exerts thyroid-hormone-like effects on mouse oligodendrocyte precursor cells. Neuroendocrinology 80:21-30.
42. Sospedra M, Martin R. 2005. Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747.
43. Sperber BR, Boyle-Walsh EA, Engleka MJ, Gadue P, Peterson AC, Stein PL, Scherer SS, McMorris FA. 2001. A unique role for Fyn in CNS myelination. J Neurosci 21:2039-2047.
44. Staugaitis SM, Smith PR, Column DR. 1990. Expression of myelin basic protein isoforms in nonglial cells. J Cell Biol 110:1719-1727.
45. Stewart DG, Davis KL. 2004. Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia. Int Rev Neurobiol 59:381-424.
46. Takai T. 2005. Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol 25:1-18.
47. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. 1994. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76:519-529.
48. Tusher VG, Tibshiram R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98:5116-5121 [E-pub 2001 Apr].
49. Wolswijk G. 1998. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601-609.
50. Yagi T, Aizawa S, Tokunaga T, Shigetam Y, Takeda N, Ikawa Y. 1993. A role for Fyn tyrosine kinase in the suckling behaviour of neonatal mice. Nature 366:742-745.
51. Yon M, Ackerley CA, Mastronardi FG, Groome N, Moscarello MA. 1996. Identification of a mitogen-activated protein kinase site in human myelin basic protein in situ. J Neuroimmunol 65:55-59.
52. Zhao C, Fancy SP, Kotter MR, Li WW, Franklin RJ. 2005. Mechanisms of CNS remyelination - the key to therapeutic advances. J Neurol Sci 233:87-91.